JP2007269812A5 - - Google Patents

Download PDF

Info

Publication number
JP2007269812A5
JP2007269812A5 JP2007154127A JP2007154127A JP2007269812A5 JP 2007269812 A5 JP2007269812 A5 JP 2007269812A5 JP 2007154127 A JP2007154127 A JP 2007154127A JP 2007154127 A JP2007154127 A JP 2007154127A JP 2007269812 A5 JP2007269812 A5 JP 2007269812A5
Authority
JP
Japan
Prior art keywords
endotoxemia
inhibitor
compound
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007154127A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007269812A (ja
JP4712001B2 (ja
Filing date
Publication date
Priority claimed from US08/461,675 external-priority patent/US5750664A/en
Application filed filed Critical
Publication of JP2007269812A publication Critical patent/JP2007269812A/ja
Publication of JP2007269812A5 publication Critical patent/JP2007269812A5/ja
Application granted granted Critical
Publication of JP4712001B2 publication Critical patent/JP4712001B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007154127A 1995-06-05 2007-06-11 エンドトキセミアの治療及び防止に有用な置換されたリポ糖類 Expired - Lifetime JP4712001B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/461,675 US5750664A (en) 1995-06-05 1995-06-05 Substituted liposaccharides useful in the treatment and prevention of endotoxemia
US08/461,675 1995-06-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP50186897A Division JP4009318B2 (ja) 1995-06-05 1996-06-05 エンドトキセミアの治療及び防止に有用な置換されたリポ糖類

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2011018401A Division JP2011121970A (ja) 1995-06-05 2011-01-31 エンドトキセミアの治療及び防止に有用な置換されたリポ糖類

Publications (3)

Publication Number Publication Date
JP2007269812A JP2007269812A (ja) 2007-10-18
JP2007269812A5 true JP2007269812A5 (enExample) 2008-01-24
JP4712001B2 JP4712001B2 (ja) 2011-06-29

Family

ID=23833509

Family Applications (3)

Application Number Title Priority Date Filing Date
JP50186897A Expired - Lifetime JP4009318B2 (ja) 1995-06-05 1996-06-05 エンドトキセミアの治療及び防止に有用な置換されたリポ糖類
JP2007154127A Expired - Lifetime JP4712001B2 (ja) 1995-06-05 2007-06-11 エンドトキセミアの治療及び防止に有用な置換されたリポ糖類
JP2011018401A Pending JP2011121970A (ja) 1995-06-05 2011-01-31 エンドトキセミアの治療及び防止に有用な置換されたリポ糖類

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP50186897A Expired - Lifetime JP4009318B2 (ja) 1995-06-05 1996-06-05 エンドトキセミアの治療及び防止に有用な置換されたリポ糖類

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2011018401A Pending JP2011121970A (ja) 1995-06-05 2011-01-31 エンドトキセミアの治療及び防止に有用な置換されたリポ糖類

Country Status (21)

Country Link
US (8) US5750664A (enExample)
EP (1) EP0853627B1 (enExample)
JP (3) JP4009318B2 (enExample)
KR (1) KR100416335B1 (enExample)
CN (1) CN1067082C (enExample)
AT (1) ATE258185T1 (enExample)
AU (1) AU707779C (enExample)
CA (1) CA2223140C (enExample)
DE (1) DE69631376T2 (enExample)
DK (1) DK0853627T3 (enExample)
ES (1) ES2214543T3 (enExample)
HU (1) HU221342B1 (enExample)
IL (2) IL122251A0 (enExample)
MX (1) MX9709502A (enExample)
NO (1) NO310239B1 (enExample)
NZ (1) NZ312299A (enExample)
PT (1) PT853627E (enExample)
RU (1) RU2170738C2 (enExample)
TW (1) TW366345B (enExample)
WO (1) WO1996039411A1 (enExample)
ZA (1) ZA964666B (enExample)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6417172B1 (en) * 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5750664A (en) * 1995-06-05 1998-05-12 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
DE69733651T2 (de) * 1996-07-03 2006-05-18 Eisai Co., Ltd. Lipid a-analoge enthaltende injektionen und verfahren zu deren herstellung
WO2000013029A1 (en) 1998-09-01 2000-03-09 Eisai Co., Ltd Method for evaluating lipid a analog-containing injections
AU2614400A (en) * 1999-01-14 2000-08-01 Eisai Co. Ltd. Administration of an anti-endotoxin drug by intravenous infusion
US20030130212A1 (en) * 1999-01-14 2003-07-10 Rossignol Daniel P. Administration of an anti-endotoxin drug by intravenous infusion
US7915238B2 (en) * 1999-02-01 2011-03-29 Eisai R & D Management Co., Ltd. Immunomodulatory compounds and methods of use thereof
US6835721B2 (en) 1999-02-01 2004-12-28 Eisai Co., Ltd. Immunomodulatory compounds and methods of use thereof
US20040006242A1 (en) * 1999-02-01 2004-01-08 Hawkins Lynn D. Immunomodulatory compounds and method of use thereof
CA2362246A1 (en) * 1999-02-10 2001-08-10 Sankyo Company, Limited Ether type lipid a1-carboxylic acid analogues
US20050101549A1 (en) * 2000-01-14 2005-05-12 Melvyn Lynn Prevention and treatment of endotoxemia and related complications associated with surgery
AU2001229479A1 (en) * 2000-01-14 2001-07-24 Eisai Co. Ltd. Prevention and treatment of endotoxemia and related complications associated with surgery
EP2452684B1 (en) 2000-02-18 2018-01-24 Eisai R&D Management Co., Ltd. Micelles
US6861512B2 (en) 2000-03-01 2005-03-01 Eisai Co., Ltd. Separation of olefinic isomers
JP2004503472A (ja) * 2000-06-09 2004-02-05 エーザイ株式会社 ボーラスまたは間欠的な静脈内注入による、抗内毒素薬の投与
US20030105033A1 (en) * 2000-06-09 2003-06-05 Rossignol Daniel P. Administration of an anti-endotoxin drug by bolus or intermittent intravenous infusion
WO2002088072A1 (en) * 2001-04-23 2002-11-07 Eisai Co., Ltd. Process for preparation of alkylene compounds
WO2002088062A1 (en) * 2001-04-23 2002-11-07 Eisai Co., Ltd. Process for preparation of alcohol derivatives
WO2002085117A1 (en) * 2001-04-24 2002-10-31 Eisai Co., Ltd. Methods and compositions for preventing and treating septic shock and endotoxemia
WO2002094019A1 (en) * 2001-05-22 2002-11-28 Eisai Co., Ltd Highly purified antiendotoxin compound
DE10125179A1 (de) * 2001-05-23 2002-12-05 Laves Ralph Georg Verwendung von LPS zur Behandlung intestinaler Entzündungsprozesse
US7727974B2 (en) * 2001-08-10 2010-06-01 Eisai R & D Management Co., Ltd. Methods of reducing the severity of mucositis
EP2338497A1 (en) 2001-08-10 2011-06-29 Eisai R&D Management Co., Ltd. Treatment and prevention of heat shock protein-associated diseases and conditions
US6913888B2 (en) * 2001-12-11 2005-07-05 Duke University Toll-like receptor 4 mutations
AU2002950657A0 (en) * 2002-08-08 2002-09-12 Alchemia Limited Derivatives of monosaccharides for drug discovery
AU2002951995A0 (en) * 2002-10-11 2002-10-31 Alchemia Limited Classes of compounds that interact with gpcrs
WO2004058788A1 (ja) * 2002-12-24 2004-07-15 Sankyo Company, Limited 右糖グルコースリピドa類縁体
KR20110120989A (ko) * 2003-01-06 2011-11-04 코릭사 코포레이션 특정의 아미노알킬 글루코사미나이드 포스페이트 화합물 및 그들의 용도
DE602004021901D1 (de) * 2003-01-28 2009-08-20 Academisch Ziekenhuis Leiden Aus ll-37 abgeleiteten peptidinhibitoren von toxinen
JP4773336B2 (ja) * 2003-02-20 2011-09-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 Ｌｐｓアンタゴニストｂ１２８７およびその立体異性体の調製のための試薬および方法
JP2006519872A (ja) * 2003-03-05 2006-08-31 エーザイ株式会社 エンドトキシン関連疾患およびエンドトキシン関連状態を予防および処置するための組成物および方法
WO2005027826A2 (en) * 2003-07-14 2005-03-31 Eisai, Co, Ltd. Methods and treating severe acute respiratory syndrome
WO2005059517A2 (en) 2003-12-16 2005-06-30 University Of Massachusetts Toll-like receptor assays
CN1930180B (zh) * 2004-01-08 2010-05-26 三共株式会社 左侧葡萄糖脂a类似物
US20070292418A1 (en) * 2005-04-26 2007-12-20 Eisai Co., Ltd. Compositions and methods for immunotherapy
CN101355928B (zh) 2005-04-26 2013-05-22 卫材R&D管理株式会社 用于癌症免疫疗法的组合物和方法
WO2006138681A2 (en) * 2005-06-17 2006-12-28 University Of Rochester Methods and compositions for enhancing immune memory by blocking intrahepatic activated t cell deletion
JP5118968B2 (ja) * 2005-08-31 2013-01-16 エーザイ・アール・アンド・ディー・マネジメント株式会社 リピッドａ類縁体の製造方法
KR101382162B1 (ko) * 2005-08-31 2014-04-07 에자이 알앤드디 매니지먼트 가부시키가이샤 리피드 ａ 유사체의 제조 방법
US7943588B2 (en) 2006-03-28 2011-05-17 Trustees Of Dartmouth College Method for preventing or treating neuropathic pain
WO2008059307A2 (en) * 2006-11-16 2008-05-22 Om Pharma Functionalized beta 1,6 glucosamine disaccharides and process for their preparation
WO2008062842A1 (fr) 2006-11-22 2008-05-29 Eisai R & D Management Co., Ltd. Sel de sodium de disaccharide et ses méthodes de production et d'utilisation
ES2392890T3 (es) * 2006-11-22 2012-12-14 Eisai R&D Management Co., Ltd. Sal sódica de un compuesto disacarídico, procedimiento para la producción de la misma y uso de la misma
EA023046B1 (ru) 2006-11-23 2016-04-29 Кадила Фармасьютикалз Лимитед Применение инактивированной нагреванием micobacterium w для снижения индуцированной tlr активности
US20110201569A1 (en) * 2009-09-16 2011-08-18 Heidi Ehrentraut Methods For Treating Myocardial Disorders
WO2011038537A1 (zh) * 2009-09-29 2011-04-07 上海南方基因科技有限公司 败血症以及败血症休克的预测、预防和治疗方法及试剂盒
GB201013785D0 (en) * 2010-08-17 2010-09-29 Ucl Business Plc Treatment
JP2012246470A (ja) 2011-05-31 2012-12-13 Sharp Corp 半導体ナノ粒子の製造方法、半導体ナノ粒子、ならびにこれを用いた蛍光体
WO2013093631A2 (en) * 2011-12-22 2013-06-27 Nanoco Technologies, Inc. Surface modified nanoparticles
EP2830631B1 (en) 2012-03-28 2017-11-22 University of Maryland, Baltimore Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections
WO2014113048A1 (en) * 2013-01-18 2014-07-24 Loma Linda University Compositions and methods for diagnosing and treating sepsis
JP6702862B2 (ja) 2013-07-11 2020-06-03 アルニラム ファーマスーティカルズ インコーポレイテッドＡｌｎｙｌａｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． オリゴヌクレオチド−リガンドコンジュゲートおよびそれらの調製方法
US9584991B1 (en) * 2014-06-19 2017-02-28 Isaac S. Daniel Method of communicating and accessing social networks using interactive coded messages
CN114712383B (zh) * 2016-03-30 2024-09-24 阿尤维斯研究有限公司 新组合物和治疗方法
EP3795576B1 (en) * 2016-09-14 2023-06-07 Genomatica, Inc. 1,3-fatty diol compounds and glycosylated derivatives thereof
JP7069120B2 (ja) * 2016-09-16 2022-05-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 エボラ（ｅｂｏｌａ）及びマールブルク（ｍａｒｂｕｒｇ）病を治療するためのｔｌｒ４拮抗薬としてのエリトランの使用方法
KR20210105879A (ko) * 2018-12-17 2021-08-27 에자이 알앤드디 매니지먼트 가부시키가이샤 리포좀을 포함하는 제형물
WO2021207218A1 (en) 2020-04-06 2021-10-14 Eisai R&D Management Co., Ltd. Treatment of nidovirales infection with eritoran
CN113527396B (zh) * 2020-04-17 2024-02-02 上海医药工业研究院 一种疫苗佐剂mpla的中间体、合成及应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495346A (en) * 1981-03-30 1985-01-22 Wisconsin Alumni Research Foundation Method of preparing a disaccharide
US4987237A (en) * 1983-08-26 1991-01-22 Ribi Immunochem Research, Inc. Derivatives of monophosphoryl lipid A
US5066794A (en) * 1984-08-24 1991-11-19 Daiichi Pharmaceutical Co., Ltd. Process for preparing a disaccharide derivative
JPS6153295A (ja) * 1984-08-24 1986-03-17 Dai Ichi Seiyaku Co Ltd ジサツカライド誘導体
NL8601551A (nl) * 1985-06-28 1987-01-16 Sandoz Ag Nieuwe saccharides, hun bereiding en farmaceutische samenstellingen, die hen bevatten.
US4912094B1 (en) * 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5158939A (en) * 1989-07-21 1992-10-27 Wisconsin Alumni Research Foundation Method of stimulating the immune systems of animals and compositions useful therefor
JP2839916B2 (ja) * 1989-10-20 1998-12-24 三共株式会社 リピドａ３位エーテル類縁体
RU1836378C (ru) 1989-12-11 1993-08-23 Санкио Компани Лимитед Способ получени аналогов липида А
JP2847319B2 (ja) 1990-05-18 1999-01-20 イビデン株式会社 電子部品搭載用多層ボンディング基板
JP3040847B2 (ja) 1990-06-22 2000-05-15 三共株式会社 リピドｘ類縁体
US5530113A (en) * 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
AU660325B2 (en) * 1991-10-11 1995-06-22 Eisai Co. Ltd. Anti-endotoxin compounds and related molecules and methods
JP3135990B2 (ja) 1992-07-31 2001-02-19 沖電気工業株式会社 パリティ付加回路
US5413785A (en) * 1993-01-27 1995-05-09 New England Deaconess Hospital Corp. Methodology employing lactobacillus GG for reduction of plasma endotoxin levels circulating in-vivo
DK0729473T3 (da) * 1993-11-17 2000-10-30 Deutsche Om Arzneimittel Gmbh Glucosamin-disaccharider, fremgangsmåde til deres fremstilling farmaceutisk sammensætning deraf og deres anvendelse
US6417172B1 (en) * 1995-06-05 2002-07-09 Eisai Co., Ltd. Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs
US5750664A (en) * 1995-06-05 1998-05-12 Eisai Co., Ltd. Substituted liposaccharides useful in the treatment and prevention of endotoxemia
JP4235193B2 (ja) 2005-06-07 2009-03-11 日本電信電話株式会社 イベント履歴蓄積装置、イベント情報検証装置、イベント履歴蓄積方法、イベント情報検証方法およびイベント情報処理システム

Similar Documents

Publication Publication Date Title
JP2007269812A5 (enExample)
JP2009502793A5 (enExample)
JP2009535462A5 (enExample)
JP2007522220A5 (enExample)
JP2009545527A5 (enExample)
JP2010501534A5 (enExample)
JP2006515626A5 (enExample)
JP2012111758A5 (enExample)
JP2009149903A5 (enExample)
JP2010019854A5 (enExample)
JP2011510079A5 (enExample)
JP2011518833A5 (enExample)
JP2010529196A5 (enExample)
JP2011508438A5 (enExample)
JP2010536766A5 (enExample)
JP2011519871A5 (enExample)
JP2011121989A5 (enExample)
JP2009013167A5 (ja) 有機金属錯体、発光材料、発光素子、及び発光装置
JP2013532130A5 (enExample)
JP2009091351A5 (enExample)
JP2009091350A5 (enExample)
EP2175660A4 (en) IMAGE PROCESSOR
JP2010500116A5 (enExample)
JP2010070692A5 (enExample)
JP2005247844A5 (enExample)